28 May '21
Appointment expands Lucira’s management team with medtech veteran EMERYVILLE, Calif. --(BUSINESS WIRE)--May 28, 2021-- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits,
13 May '21
EMERYVILLE, Calif, May 13, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health," "Lucira" or the "Company") (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported financial
12 May '21
This FDA EUA first and only PCR quality, single-use, COVID-19 at home, self-test kit is available for $55 to all Amazon US customers EMERYVILLE, Calif. --(BUSINESS WIRE)--May 12, 2021-- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization
29 Apr '21
EMERYVILLE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will
26 Apr '21
LUCIRA™ CHECK IT COVID-19 Self-Test Receives Interim Order Authorization EMERYVILLE, Calif. --(BUSINESS WIRE)--Apr. 26, 2021-- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test
22 Apr '21
Lucira’s lab quality PCR test has FDA OTC (over the counter) clearance for all EMERYVILLE, Calif. --(BUSINESS WIRE)--Apr. 22, 2021-- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease
Displaying 1 - 10 of 14